Brenda Marczi

Dr. Marczi joined us as Senior Vice President, Regulatory Affairs in 2021. Previously, she was Vice President of Regulatory Affairs at Ferring Pharmaceuticals, Inc. and past positions included Vice President Regulatory Affairs at Eagle Pharmaceuticals, Inc, and at Sapphire Therapeutics (now Helsinn Healthcare SA). During her career, she has led Regulatory groups in the development and commercialization of compounds (including oncology) across all regulatory areas including nonclinical, clinical, CMC, regulatory operations, regulatory strategy and advertising and promotion. including oncology. Dr. Marczi received her BS and MS degrees in Pharmacy from Rutgers University, her PharmD from the University of Maryland, and her MBA from the University of Pennsylvania (Wharton).